Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psoriasis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psoriasis
    Fumaric Acid Ester Safe and Effective Against Psoriasis in Patients Receiving Medication for Comorbidities: Presented at EADV - (DGDispatch)
    Infliximab More Effective Than Methotrexate in Patients With Moderate to Severe Plaque Psoriasis: Presented at EADV - (DGDispatch)
    Patients With Psoriasis Experience Improved Quality of Life Following Adalimumab Treatment: Presented at EADV - (DGDispatch)
    Adalimumab Yields Fast and Sustainable Scalp and Nail Results in Patients With Psoriasis: Presented at EADV - (DGDispatch)
    Comorbidities of Psoriasis Create Higher Healthcare Costs: Presented at EADV - (DGDispatch)

    News archive

     Recent webcasts/CME - Psoriasis
    • Using Biologics to Improve Both Physical and Social Function in Rheumatic Diseases
    • Rheumatic Diseases: Using Anti-TNF-alpha Agents to Improve Everyday Patient Function
    • Management of Psoriasis: Update for the Pharmacist
      Exploring Psoriatic Arthritis: Bridging Dermatology and Rheumatology
      Moderate-to-Severe Psoriasis and Psoriatic Arthritis: Reducing the Clinical and Economic Burden Through Effective Treatment Protocols

      Webcasts/CME archive

       Recent cases - Psoriasis
        Therapeutic Effect of Hyperbaric Oxygen in Psoriasis Vulgaris: Two Case Reports and a Review of the Literature
        Exacerbation of Psoriasis with beta-Blocker Therapy
        Concomitant Xeroderma Pigmentosum and Disseminated Small Plaque Psoriasis - The First Case of an Antinomic Association: A Case Report
        Extensive Psoriasis Induced by Pegylated Interferon: A Case Report
        Pulmonary Sarcoidosis Associated with Psoriasis Vulgaris: Coincidental Occurrence or Causal Association? Case Report

        Cases archive
          




        my personal edition > psoriasis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Calcitriol Better Than Calcipotriol For Psoriasis In Sensitive Areas

        A DGReview of :"Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 micro g g-1 ointment and calcipotriol 50 micro g g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas."
        British Journal of Dermatology

        03/06/2003
        By James Adams


        Calcitriol ointment appears to be better tolerated and more effective than calcipotriol ointment for the treatment of plaque psoriasis involving facial, hairline, retroauricular and flexural areas.

        Side effects of topical corticosteroids and the potential for irritation from vitamin D3 derivatives makes treating psoriasis difficult in sensitive areas, investigators explain. Previous studies have shown that calcitriol ointment, the naturally occurring and hormonally active form of vitamin D3, is safe and effective for psoriasis of the trunk and limbs.

        The investigators, from multiple French and Bulgarian institutions including the Hopital de l'Archet 2 in Nice and the Bulgaria Military Medical Academy in Sofia, compared the safety and efficacy of calcitriol 3 micrograms/g ointment with calcipotriol 50 mcg/g ointment in a multi-centre, randomized, investigator-blinded study.

        The two treatments were compared intra-individually in 75 subjects with mild to moderate chronic plaque psoriasis affecting sensitive areas.

        A pair of bilateral and symmetrical lesions was selected from each area. Perilesional erythema, oedema and stinging and burning were all assessed. The investigators rated local tolerability and global improvement. Subjects were also asked to evaluate tolerability and efficacy and to report their preference for either treatment.

        Results showed that both treatments cleared at least one target lesion in 28% of the subjects. The investigator-assessed global improvement was significantly greater for the lesions treated with calcitriol.

        Perilesional erythema, perilesional oedema and stinging and burning were all significantly less severe with calcitriol compared with calcipotriol.

        Reports of local tolerability by the subjects themselves significantly favoured calcitriol, and the subjects preferred calcitriol to calcipotriol ointment.
        Br J Dermatol 2003;148:2:326-333. "Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 micro g g-1 ointment and calcipotriol 50 micro g g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send